Relationship register · Person
JI
James I. Healy, M.D., Ph.D. Dr. James I. Healy is a general partner, managing partner and partner at Sofinnova Ventures, where he focuses on financing public and private clinical-stage biopharmaceutical companies.
Country United States
Also known as Jim, Dr. James I. Healy, James Healy, MD, PhD
Relationship register 11 documented relationships
Documented relationships 11 documented relationships James I. Healy, M.D., Ph.D. → Bayer Corporation (Bayer Pharmaceuticals) · Employment James I. Healy, M.D., Ph.D. → ISTA Pharmaceuticals Inc. · Employment James I. Healy, M.D., Ph.D. → Human Genome Center at Lawrence Berkeley Labs · Employment James I. Healy, M.D., Ph.D. → Affymetrix · Employment James I. Healy, M.D., Ph.D. → NVCA MedIC Coalition · Advisory role James I. Healy, M.D., Ph.D. → Sanderling Ventures · Employment James I. Healy, M.D., Ph.D. → Hyperion Therapeutics, Inc. · Board seat James I. Healy, M.D., Ph.D. → Hyperion Therapeutics, Inc. · Board seat James I. Healy, M.D., Ph.D. → Natera, Inc. · Board seat James I. Healy, M.D., Ph.D. → Ascendis Pharma A/S · Board seat James I. Healy, M.D., Ph.D. → BioAge Labs, Inc. · Board seat James I. Healy, M.D., Ph.D. James I. Healy, M.D., Ph.D. Bayer Corporation (Bayer Pharmaceuticals) Bayer Corporation (Bayer Pharmaceuticals) ISTA Pharmaceuticals Inc. ISTA Pharmaceuticals Inc. Human Genome Center at Lawrence Berkeley Labs Human Genome Center at Lawrence Berkeley Labs Affymetrix Affymetrix NVCA MedIC Coalition NVCA MedIC Coalition Sanderling Ventures Sanderling Ventures Hyperion Therapeutics, Inc. Hyperion Therapeutics, Inc. Natera, Inc. Natera, Inc. Ascendis Pharma A/S Ascendis Pharma A/S BioAge Labs, Inc. BioAge Labs, Inc. Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount. Detailed register Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “a manufacturing position”.
Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “helped to lead the discovery group”.
Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “helped design, test and then publish on the first murine gene chips”.
Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “Advisory Board”.
1998 · 2000 Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “Partner”.
2006 Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Function or object indicated by the source: “Director.”
July 2009 Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “Chairman”.
November 2014 Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “Director”.
November 2014 Reported 1 James I. Healy M.d., Ph.d. biography.omicsonline.org Role or object indicated by the source: “Independent Director”.
June 10, 2026 Reported 2 BioAge Labs Shareholders Reelect Directors, Ratify Auditor theglobeandmail.com Position or object indicated by the source: “Class II director”.
Sources 1. 2. BioAge Labs Shareholders Reelect Directors, Ratify Auditor
Web page theglobeandmail.com
Translate displayed information
View original ↑ Back to text